|Περιγραφή||SUMMARY In this review the current aspects concerning the application of leukocytapheresis in patients with inflammatory bowel disease are briefly discussed.
Leukocytapheresis has already been applied in patients suffering mainly from diseases affecting the immunological balance. The procedure has recently been tried in patients with ulcerative colitis
and Crohns disease as well, with promising results. Leukocytapheresis is gaining in interest as a therapeutic procedure of the near future, because it removes - in a short time- a number of
immunologically active cells, which are well known to actively participate in the inflammatory cascade, leading to tissue damage. However, further studies are needed in order to better clarify the
role of leukocytapheresis in the maintenance treatment of patients with inflammatory bowel disease, either alone, or in combination with drugs of known efficacy in IBD. Key words: Apheresis,
Leucocytapheresis, Inflammatory bowel disease, Ulcerative colitis, Crohns disease|